Provided by Tiger Trade Technology Pte. Ltd.

Bio-Techne

50.95
-1.7500-3.32%
Post-market: 50.950.00000.00%17:12 EDT
Volume:1.79M
Turnover:91.37M
Market Cap:7.94B
PE:98.12
High:53.60
Open:52.62
Low:50.56
Close:52.70
52wk High:72.16
52wk Low:46.01
Shares:155.81M
Float Shares:154.93M
Volume Ratio:0.93
T/O Rate:1.15%
Dividend:0.32
Dividend Rate:0.63%
EPS(TTM):0.5193
EPS(LYR):0.4600
ROE:3.97%
ROA:6.52%
PB:3.95
PE(LYR):110.76

Loading ...

Table: G-TECH Optoelectronics Feb Rev NT$173.5M Vs NT$100.5M

Dow Jones
·
Mar 06

Bio-Techne Files Initial Beneficial Ownership Statement for Steven C. Crouse, President - Diag & Spatial Bi

Reuters
·
Mar 05

Bio-Techne Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 05

Bio-Techne Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Mar 04

Bio-Techne Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Mar 03

Bio-Techne Corp. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Feb 28

Bio-Techne Corp. Stock Rises 5.2%, Outperforms Peers

Dow Jones
·
Feb 25

Bio-Techne Corp. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Feb 21

Bio-Techne Insider Move: Director Cashes In on Shares in Notable Stock Sale

TIPRANKS
·
Feb 20

Bio-Techne Director Amy E. Herr Disposes of Common Shares

Reuters
·
Feb 20

Bio-Techne Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Feb 19

Cleo Diagnostics Selects Bio-Techne's Platform as Immunoassay Instrument for Ovarian Cancer Blood Test; Shares Jump 3%

MT Newswires Live
·
Feb 18

Bio-Techne Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Feb 18

Will Bio-Techne (TECH) Turn Ella’s EU Clinical Clearance Into A Precision-Medicine Edge?

Simply Wall St.
·
Feb 17

BRIEF-Bio-Techne Corp's Ella Platform Receives CE-Ivd Marking, Available For Sale In EU

Reuters
·
Feb 16

Bio-Techne Corp - Ella Benchtop Immunoassay Platform Has Received Ce-Ivd Marking and Is NOW Available for Sale in European Union

THOMSON REUTERS
·
Feb 16

Assessing Bio-Techne (TECH) Valuation After Earnings Beat And New 3D Research Tool Launch

Simply Wall St.
·
Feb 16

Bio-Techne Corp. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Feb 12

Exosome Diagnostics Reports Year-End Results With Sales and Net Income Figures for 2025

Reuters
·
Feb 12

BRIEF-Bio-Techne Announces Changes To Its Leadership Team

Reuters
·
Feb 11